MARISA SERRATO: Open Payments
NPI 1215765870 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,241 in 45 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $175 · 2025 $1,241
Food & beverage: $1,228Travel & lodging: $13
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 6 | $282 |
| PFIZER INC. | 14 | $275 |
| GENZYME CORPORATION | 9 | $275 |
| Regeneron Healthcare Solutions, Inc. | 3 | $146 |
| Incyte Corporation | 4 | $73 |
| Biofrontera Inc. | 3 | $54 |
| Lilly USA, LLC | 2 | $42 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
Products named: DUPIXENT, Zoryve, CIBINQO, OPZELURA, TALTZ, COSENTYX, ILUMYA, NUZYRA.
Industry payments across CA — which companies pay providers there.
